Opportunity
Simpler Grants.gov #PAR-26-105
NIH Grant for Innovative HIV 3C Research in Pediatric and Maternal Populations
Buyer
National Institutes of Health
Posted
February 06, 2026
Respond By
September 25, 2026
Identifier
PAR-26-105
NAICS
541715, 541714
This opportunity from the National Institutes of Health (NIH), specifically the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), seeks to fund pioneering research on HIV-related chronic conditions, coinfections, and comorbidities (3C): - Government Buyer: - National Institutes of Health (NIH) - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) - Program: ORACLE 3C (DP2 mechanism) - Purpose: - Support early-career investigators in innovative research on HIV 3C - Focus on preventive and therapeutic strategies based on HIV-specific pathways and mechanisms - Emphasis on pediatric and maternal populations - Notable Requirements: - Encourages participation from fields such as mathematics, engineering, computer science, and artificial intelligence - Open to a wide range of applicants: nonprofits, government, educational, business, tribal, and foreign institutions - Funding Details: - Funding Opportunity Number: PAR-26-105 - Estimated total program funding: $1,960,000 - Expected number of awards: 4 - No specific OEMs, vendors, or product procurements are involved, as this is a research grant opportunity - Place of Performance: - National Institutes of Health (federal office)
Description
The National Institutes of Health (NICHD) is using the DP2 mechanism to support early-career investigators conducting pioneering research on HIV-related chronic conditions, coinfections, and comorbidities (3C). The research aims to develop preventive and therapeutic strategies based on understanding HIV-specific pathways and mechanisms, focusing especially on pediatric and maternal populations. The solicitation encourages innovative approaches from researchers in diverse fields including mathematics, engineering, computer science, and AI. This funding opportunity supports transformative research on HIV 3Cs by investigators in the early stages of an independent career.